Hensify
Nanobiotix
Nanobiotix’s Hensify NBTXR3 is a device that treats soft tissue sarcoma.
The Paris-based company’s Hensify is designed to destroy tumors through physical cell death when activated by radiotherapy. It can be used alone or in combination with anti-PD-1 immunotherapy, across different standards of care.
Nanobiotix is using nanophysics applied to the heart of the cell to treat cancer.